Weekly Closed-End Fund Roundup (September 20, 2026)

Stanford Chemist Investing Group Leader Follow Summary Closed-end fund sector performance was weak this week, with just 2 of 26 sectors positive on price and 1 positive on NAV; the average sector discount widened to -6.43%. Commodities led sector price returns (+1.36%) and NAV returns (+1.25%), while Real Estate lagged on price (-2.58%) and MLPs lagged on NAV (-2.40%); Sector Equity trades at the widest premium (+21.29%), and U.S. Equity at the widest discount (-14.11%). Key corporate actions include HERZ's tender offer for up to 5% of outstanding shares at 97.5% of NAV, ASGI's 1-for-3 transferable rights offering, and BCAT's 1-for-5 rights offering still open through October 21. Looking for a portfolio of ideas like this one? Members of CEF/ETF Income Laboratory get exclusive access to our subscriber-only portfolios. Learn More » cyano66/iStock via Getty Images The Weekly Closed-End Fund Roundup will be put out at the start of each week to summarize recent price movements in closed-end fund sectors in the last week, as well as to highlight recently concluded or This article was written by Stanford Chemist 20.85K Followers Follow Stanford Chemist is a scientific researcher by training. For the past decade he has been providing analysis and evidence-based ways of generating profitable investments with CEFs and ETFs. He leads the investing group CEF/ETF Income Laboratory. Features of the service include: managed income portfolios (targeting safe and reliable ~8% yields) making use of high-yield opportunities in the CEF and ETF fund space. These are geared toward both active and passive investors of all experience levels. The vast majority of {CEF/ETF Income Laboratory} holdings are also monthly-payers, for faster compounding and steady income streams. Other features include 24/7 chat, and trade alerts. Analyst’s Disclosure: I/we have a beneficial long position in the shares of BANX, BGB, BME, DHF, EIM, ETG, ETY, FLC, KYN, NFJ, OCCI, OXLC, PCN, PDO, PDX, PFO, PML, RA, RLTY, SWZ either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.